Pemazyre (pemigatinib)

pCPA File Number: 21817
Negotiation Status:
Negotiations were not pursued
Indication(s):
Unresectable Locally Advanced or Metastatic Cholangiocarcinoma (CCA) in adults with previously treated CCA with a FGFR2 fusion or other rearrangement
Sponsor/Manufacturer:
Incyte Biosciences Canada Corporation
CDA-AMC Project Number:
PC0252-000
pCPA Engagement Letter Issued:
Not Applicable
Negotiation Process Concluded: